The email you have inserted is not registered at Medicon Valley Online. If you wish to gain access to a specific organization profile please speak to one of the registered contacts of that organization. The registered contacts can usually be found on the profile page of that organization.
The email you have inserted is not in our database. Plese try again!
To add a compound to a pipeline your organisation needs to be registered as a biotech or pharmaceutical company at Medicon Valley Online. If your organisation is already registered please click on the Sign in button below. If you wish to register a new organisation, please click the Register button.
To add a service your organisation needs to be registered at Medicon Valley Online as a member of Medicon Valley Alliance and have paid the one time fee of 2300 EUR for the service section. If this has been accomplished please, just click the Sign in button below. If you want access to the services section or media about it please send your contact details to contact@mediconvalleyonline.com and we will get back to you.
Please enter your email address in the field below. Once submitted a message, with an authorization link, will be sent to this address so that you can set a new password for your account. You will have access to you account again in a couple of minutes. Thank you for your patience.
Drug compounds in clinical development by Biotech and Pharmaceutical companies located in Medicon Valley. Listed compounds must have their clinical development managed or administered from a site within Medicon Valley.
Compound
Company
Primary Therapeutical Area / Indication
Drug development
CVAC-301 (CV-301)
Cancers and Other Neoplasms / Breast Neoplasms
Phase II
Daratumumab
Cancers and Other Neoplasms / Multiple Myeloma
Phase II
MVA-BN® HER2
Cancers and Other Neoplasms / Breast Neoplasms
Phase II
MVA-BN® PRO
Cancers and Other Neoplasms / Prostatic Neoplasms
Phase II
MelCancerVac®
Cancers and Other Neoplasms / Colorectal Neoplasms
Phase II
Prosenze®
Cancers and Other Neoplasms / Prostatic Neoplasms
Phase II
Sym004
Cancers and Other Neoplasms / Carcinoma, Squamous Cell
Phase II
TB-403
Cancers and Other Neoplasms / Glioblastoma
Phase II
ALECSAT
Cancers and Other Neoplasms / Prostatic Neoplasms
Phase I
AT001/r84
Cancers and Other Neoplasms / Angiogenesis
Phase I
BI-505
Cancers and Other Neoplasms / Multiple Myeloma
Phase I
EZN-2968
Cancers and Other Neoplasms / Solid Tumors and Lymphomas
Phase I
EZN-3042
Cancers and Other Neoplasms / Leukemia
Phase I
EZN-4176
Cancers and Other Neoplasms / Prostatic Neoplasms
Phase I
LiPlaCis®
Cancers and Other Neoplasms
Phase I
ADC-1013
Cancers and Other Neoplasms
Pre-clinical
ADC-1014
Cancers and Other Neoplasms
Pre-clinical
AT006
Cancers and Other Neoplasms
Pre-clinical
AT008/CCR4
Cancers and Other Neoplasms
Pre-clinical
HuMax-CD74-ADC
Cancers and Other Neoplasms / Solid Tumors and Lymphomas